Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/Explore/US Market Price/Stocks/ABCL
icon
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

AbCellera Biologics Inc (ABCL) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

AbCellera Biologics (ABCL) trades at $6.465, down 4.08% on the day, amid mixed financials with a -181.74% net income margin but a strong $876M collaboration with Jazz Pharmaceuticals announced June 17, 2026. Technicals are bullish with a golden cross, while fundamentals show deep losses despite revenue growth from $29M in 2024 to $75M in 2025. Analyst sentiment is overwhelmingly positive with a $9.00 consensus target.
The outlook hinges on pipeline execution, with Phase 2 data for ABCL635 due in Q3 2026 offering near-term catalyst potential. Risks include persistent cash burn and high valuation multiples despite negative earnings. The stock presents a high-risk, high-reward opportunity driven by clinical milestones and partnership value.
Read full analysis

Key Stats

  • Market Cap
    $1.97B
  • Volume
    -
  • Sector
    Health
  • 52W High
    $8.12
  • 52W Low
    $2.78
  • Typical Hold Time
    -
  • Enterprise Value
    $1.61B
  • Div Yield
    -
  • Trading Activity
    -
$6.47
52W Low: $2.78
05 Feb 2026
52W High: $8.12
29 Jun 2026

Track AbCellera Biologics Inc (ABCL) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, AbCellera Biologics Inc has traded between a low of $2.78 and a high of $8.12, highlighting its annual price range. Buy and sell AbCellera Biologics Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About AbCellera Biologics Inc

AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.

Most Recent News

Content is generated by Aura AI

Medicus Pharma's redesigned Teverelix study gets FDA and IRB approval, cutting costs and patient numbers significantly.

Medicus Pharma announced that its redesigned clinical study protocol for Teverelix, a next-generation hormone antagonist for men's health, has received approval from the Institutional Review Board and conditional acceptance from the FDA. The revised ...

Market News
4 hours ago
Proactive Investors
Bullish
news icon
pluang ai news

Fanatics aims to become the most valuable sports company, focusing on merchandise, collectibles, and betting.

Fanatics, led by CEO Michael Rubin, has grown from a sports merchandise retailer into a major global sports platform with revenues nearing $14 billion in 2026. The company dominates sports apparel and has expanded into collectibles, sports betting, a...

Market News
6 hours ago
CNBC
Bullish
news icon
pluang ai news

iShares MSCI Indonesia ETF trades cheap but faces technical and sector risks limiting gains.

The iShares MSCI Indonesia ETF (EIDO) is currently trading at a low valuation of 8.7 times price-to-earnings, making it appear cheap. However, its heavy exposure to financials (44%) and modest long-term earnings growth of 5.9% limit its upside potent...

Market News
6 hours ago
Seeking Alpha
Neutral
pluang ai news
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $1.97B
  • Volume
    -
  • Sector
    Health
  • 52W High
    $8.12
  • 52W Low
    $2.78
  • Typical Hold Time
    -
  • Enterprise Value
    $1.61B
  • Div Yield
    -
  • Trading Activity
    -
$6.47
52W Low: $2.78
05 Feb 2026
52W High: $8.12
29 Jun 2026

Track AbCellera Biologics Inc (ABCL) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, AbCellera Biologics Inc has traded between a low of $2.78 and a high of $8.12, highlighting its annual price range. Buy and sell AbCellera Biologics Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!